메뉴 건너뛰기




Volumn 50, Issue 5, 2009, Pages 1351-1359

Impact of pegylated interferon and ribavirin on morbidity and mortality in patients with chronic hepatitis C and normal aminotransferases in France

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; AMINOTRANSFERASE; INTERFERON; PEGINTERFERON; RIBAVIRIN;

EID: 72949119342     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.23159     Document Type: Article
Times cited : (30)

References (39)
  • 1
    • 17344363641 scopus 로고    scopus 로고
    • Factors associated with serum alanine transaminase activity in healthy subjects: Consequences for the definition of normal values, for selection of blood donors, and for patients with chronic hepatitis C
    • Piton A, Poynard T, ImbertBismut F, Khalil L, Delattre J, Pelissier E, et al. Factors associated with serum alanine transaminase activity in healthy subjects: consequences for the definition of normal values, for selection of blood donors, and for patients with chronic hepatitis C. HEPATOLOGY 1998;27:1213-1219.
    • (1998) HEPATOLOGY , vol.27 , pp. 1213-1219
    • Piton, A.1    Poynard, T.2    ImbertBismut, F.3    Khalil, L.4    Delattre, J.5    Pelissier, E.6
  • 2
    • 0033431808 scopus 로고    scopus 로고
    • Treatment of patients with chronic hepatitisCand normal ALT levels
    • Tassopoulos N. Treatment of patients with chronic hepatitisCand normal ALT levels. J Hepatol 1999;31(Suppl. 1):193-196.
    • (1999) J Hepatol , vol.31 , Issue.SUPPL. 1 , pp. 193-196
    • Tassopoulos, N.1
  • 4
    • 0034761962 scopus 로고    scopus 로고
    • Prospective study on anti-hepatitis C virus-positive patients with persistently normal serum alanine transaminase with or without detectable serum hepatitis C virus RNA
    • Martinot-Peignoux M, Boyer N, Cazals-Hatem D, Pham BN, Gervais A, Le Breton V, et al. Prospective study on anti-hepatitis C virus-positive patients with persistently normal serum alanine transaminase with or without detectable serum hepatitis C virus RNA. HEPATOLOGY 2001;34:1000-1005.
    • (2001) HEPATOLOGY , vol.34 , pp. 1000-1005
    • Martinot-Peignoux, M.1    Boyer, N.2    Cazals-Hatem, D.3    Pham, B.N.4    Gervais, A.5    Le Breton, V.6
  • 5
    • 85005773666 scopus 로고    scopus 로고
    • Natural history of hepatitis C virus carriers with persistently normal aminotransferase levels
    • Persico M, Persico E, Suozzo R, Conte S, De Seta M, Coppola L, et al. Natural history of hepatitis C virus carriers with persistently normal aminotransferase levels. Gastroenterology 2000;118:760-764.
    • (2000) Gastroenterology , vol.118 , pp. 760-764
    • Persico, M.1    Persico, E.2    Suozzo, R.3    Conte, S.4    De Seta, M.5    Coppola, L.6
  • 7
    • 0031952915 scopus 로고    scopus 로고
    • Slow progression rate of fibrosis in hepatitis C virus patients with persistently normal alanine transaminase activity
    • Mathurin P, Moussalli J, Cadranel J-F, Thibault V, Charlotte F, Dumouchel P, et al. Slow progression rate of fibrosis in hepatitis C virus patients with persistently normal alanine transaminase activity. HEPATOLOGY 1998;27:868-872.
    • (1998) HEPATOLOGY , vol.27 , pp. 868-872
    • Mathurin, P.1    Moussalli, J.2    Cadranel, J.-F.3    Thibault, V.4    Charlotte, F.5    Dumouchel, P.6
  • 8
    • 72949124703 scopus 로고    scopus 로고
    • Consensus statement. Presented at EASL International Consensus Conference on Hepatitis C, Paris, February 26-27, 1999. J Hepatol 1999; 31(Suppl. 1):3-8.
    • Consensus statement. Presented at EASL International Consensus Conference on Hepatitis C, Paris, February 26-27, 1999. J Hepatol 1999; 31(Suppl. 1):3-8.
  • 10
    • 0034864360 scopus 로고    scopus 로고
    • The natural course of hepatitis C virus infection after 22 years in a unique homogenous cohort: Spontaneous viral clearance and chronic HCV infection
    • Barrett S, Goh J, Coughlan B, Ryan E, Stewart S, Cockram A, et al. The natural course of hepatitis C virus infection after 22 years in a unique homogenous cohort: spontaneous viral clearance and chronic HCV infection. Gut 2001;49:423-430.
    • (2001) Gut , vol.49 , pp. 423-430
    • Barrett, S.1    Goh, J.2    Coughlan, B.3    Ryan, E.4    Stewart, S.5    Cockram, A.6
  • 11
    • 0037383891 scopus 로고    scopus 로고
    • HCV carriers with persistently normal aminotransferase levels: Normal does not always mean healthy
    • Puoti C. HCV carriers with persistently normal aminotransferase levels: normal does not always mean healthy. J Hepatol 2003;38:529-532.
    • (2003) J Hepatol , vol.38 , pp. 529-532
    • Puoti, C.1
  • 12
    • 2142838857 scopus 로고    scopus 로고
    • Impaired quality of life in patients with chronic hepatitis C and persistently normal transminase levels [Abstract 606]
    • von Wagner M, Lee J-H, Fried R, Kronenberger B, Sarrazin C, Zeuzem S. Impaired quality of life in patients with chronic hepatitis C and persistently normal transminase levels [Abstract 606]. HEPATOLOGY 2003;38(4 Suppl. 1):454A.
    • (2003) HEPATOLOGY , vol.38 , Issue.4 SUPPL. 1
    • von Wagner, M.1    Lee, J.-H.2    Fried, R.3    Kronenberger, B.4    Sarrazin, C.5    Zeuzem, S.6
  • 13
    • 61749098966 scopus 로고    scopus 로고
    • Incidence of hepatocellular carcinoma in hepatitis C carriers with normal alanine aminotransferase levels
    • Kumada T, Toyoda H, Kiriyama S, Sone Y, Tanikawa M, Hisanaga Y, et al. Incidence of hepatocellular carcinoma in hepatitis C carriers with normal alanine aminotransferase levels. J Hepatol 2009;50:729-735.
    • (2009) J Hepatol , vol.50 , pp. 729-735
    • Kumada, T.1    Toyoda, H.2    Kiriyama, S.3    Sone, Y.4    Tanikawa, M.5    Hisanaga, Y.6
  • 14
    • 1542378867 scopus 로고    scopus 로고
    • PegIFN-alpha2a and ribavirin combination therapy in chronic hepatitis C: A randomized study of treatment duration and ribavirin dose
    • Hadziyannis SJ, Sette H Jr, Morgan TR, Balan V, Diago M, Marcellin P, et al. PegIFN-alpha2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin dose. Ann Intern Med 2004;140:346-355.
    • (2004) Ann Intern Med , vol.140 , pp. 346-355
    • Hadziyannis, S.J.1    Sette Jr, H.2    Morgan, T.R.3    Balan, V.4    Diago, M.5    Marcellin, P.6
  • 15
    • 9644262441 scopus 로고    scopus 로고
    • PegIFN alfa-2a (40 kilodaltons) and ribavirin in patients with chronic hepatitis C and normal aminotransferase levels
    • Zeuzem S, Diago M, Gane E, Reddy KR, Pockros P, Prati D, et al. PegIFN alfa-2a (40 kilodaltons) and ribavirin in patients with chronic hepatitis C and normal aminotransferase levels. Gastroenterology 2004;127:1724-1732.
    • (2004) Gastroenterology , vol.127 , pp. 1724-1732
    • Zeuzem, S.1    Diago, M.2    Gane, E.3    Reddy, K.R.4    Pockros, P.5    Prati, D.6
  • 16
    • 46149090112 scopus 로고    scopus 로고
    • Impact of viral eradication on mortality related to hepatitis C: A modeling approach in France
    • Deuffic-Burban S, Deltenre P, Louvet A, Canva V, Dharancy S, Hollebecque A, et al. Impact of viral eradication on mortality related to hepatitis C: a modeling approach in France. J Hepatol 2008;49:175-183.
    • (2008) J Hepatol , vol.49 , pp. 175-183
    • Deuffic-Burban, S.1    Deltenre, P.2    Louvet, A.3    Canva, V.4    Dharancy, S.5    Hollebecque, A.6
  • 19
    • 0033917644 scopus 로고    scopus 로고
    • Hepatitis C virus related cirrhosis: Time to occurrence of hepatocellular carcinoma and death
    • Degos F, Christidis C, Ganne-Carrié N, Farmachidi J-P, Degott C, Guettier C, et al. Hepatitis C virus related cirrhosis: time to occurrence of hepatocellular carcinoma and death. Gut 2000;47:131-136.
    • (2000) Gut , vol.47 , pp. 131-136
    • Degos, F.1    Christidis, C.2    Ganne-Carrié, N.3    Farmachidi, J.-P.4    Degott, C.5    Guettier, C.6
  • 20
    • 28844490547 scopus 로고    scopus 로고
    • Natural history and prognostic indicators of survival in cirrhosis: A systematic review of 118 studies
    • D'Amico G, Garcia-Tsao G, Pagliaro L. Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies. J Hepatol 2006;44:217-231.
    • (2006) J Hepatol , vol.44 , pp. 217-231
    • D'Amico, G.1    Garcia-Tsao, G.2    Pagliaro, L.3
  • 21
    • 0035200712 scopus 로고    scopus 로고
    • Trends in survival of patients with hepatocellular carcinoma between 1977 and 1996 in the United States
    • El-Serag HB, Mason AC, Key C. Trends in survival of patients with hepatocellular carcinoma between 1977 and 1996 in the United States. HEPATOLOGY 2001;33:62-65.
    • (2001) HEPATOLOGY , vol.33 , pp. 62-65
    • El-Serag, H.B.1    Mason, A.C.2    Key, C.3
  • 22
    • 72949085597 scopus 로고    scopus 로고
    • Accessed July 13, 2009
    • Global Health Observatory/WHOSIS. http://www.who.int/whosis/mort/ download/en/index.html. Accessed July 13, 2009.
    • Global Health Observatory/WHOSIS
  • 23
    • 79960830568 scopus 로고    scopus 로고
    • Accessed July 13, 2009
    • U.S. Centers for Disease Control and Prevention. Viral hepatitis. http://www.cdc.gov/ncidod/diseases/hepatitis/resource/PDFs/disease-burden.pdf. Accessed July 13, 2009.
    • Viral hepatitis
  • 24
    • 0030933395 scopus 로고    scopus 로고
    • Poynard T, Bedossa P, Opolon P. Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups. Lancet 1997;349:825-832.
    • Poynard T, Bedossa P, Opolon P. Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups. Lancet 1997;349:825-832.
  • 25
    • 0032748876 scopus 로고    scopus 로고
    • Hepatitis C virus genotypes in France: Relationship with epidemiology, pathogenicity and response to interferon therapy. The GEMHEP
    • Martinot-Peignoux M, Roudot-Thoraval F, Mendel I, Coste J, Izopet J, Duverlie G, et al. Hepatitis C virus genotypes in France: relationship with epidemiology, pathogenicity and response to interferon therapy. The GEMHEP. J Viral Hepat 1999;6:435-443.
    • (1999) J Viral Hepat , vol.6 , pp. 435-443
    • Martinot-Peignoux, M.1    Roudot-Thoraval, F.2    Mendel, I.3    Coste, J.4    Izopet, J.5    Duverlie, G.6
  • 26
    • 0030912791 scopus 로고    scopus 로고
    • the Collaborative Study Group. Hepatitis C in a French population-based survey, 1994: Seroprevalence, frequency of viremia, genotype distribution, and risk factors
    • Dubois F, Desenclos JC, Mariotte N, Goudeau A, the Collaborative Study Group. Hepatitis C in a French population-based survey, 1994: seroprevalence, frequency of viremia, genotype distribution, and risk factors. HEPATOLOGY 1997;25:1490-1496.
    • (1997) HEPATOLOGY , vol.25 , pp. 1490-1496
    • Dubois, F.1    Desenclos, J.C.2    Mariotte, N.3    Goudeau, A.4
  • 29
    • 44949132603 scopus 로고    scopus 로고
    • Efficacy of peginterferon alpha-2a and ribavirin in 2101 patients with HCV infection in real-life clinical practice: Results of the French HEPATYS study [Abstract]
    • Bourliere M, Ouzan D, Rosenheim M, Doffoel M, Marcellin P, Pawlotsky JM, et al. Efficacy of peginterferon alpha-2a and ribavirin in 2101 patients with HCV infection in real-life clinical practice: results of the French HEPATYS study [Abstract]. HEPATOLOGY 2007;46:366A.
    • (2007) HEPATOLOGY , vol.46
    • Bourliere, M.1    Ouzan, D.2    Rosenheim, M.3    Doffoel, M.4    Marcellin, P.5    Pawlotsky, J.M.6
  • 31
    • 0032547938 scopus 로고    scopus 로고
    • Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C
    • McHutchison JG, Gordon SC, Schiff ER, Shiffman ML, Lee WM, Rustgi VK, et al. Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. N Engl J Med 1998;339:1485-1492.
    • (1998) N Engl J Med , vol.339 , pp. 1485-1492
    • McHutchison, J.G.1    Gordon, S.C.2    Schiff, E.R.3    Shiffman, M.L.4    Lee, W.M.5    Rustgi, V.K.6
  • 32
    • 0032801727 scopus 로고    scopus 로고
    • Interferon-ribavirin for chronic hepatitis C with and without cirrhosis: Analysis of individual patient data of six controlled trials
    • Schalm SW, Weiland O, Hansen BE, Milella M, Lai FY, Hollander A, et al. Interferon-ribavirin for chronic hepatitis C with and without cirrhosis: analysis of individual patient data of six controlled trials. Gastroenterology 1999;117:408-413.
    • (1999) Gastroenterology , vol.117 , pp. 408-413
    • Schalm, S.W.1    Weiland, O.2    Hansen, B.E.3    Milella, M.4    Lai, F.Y.5    Hollander, A.6
  • 34
    • 38049012007 scopus 로고    scopus 로고
    • Mortality related to chronic hepatitis B and chronic hepatitis C in France: Evidence for the role of HIV coinfection and alcohol consumption
    • Marcellin P, Pequignot F, Delarocque-Astagneau E, Zarski JP, Ganne N, Hillon P, et al. Mortality related to chronic hepatitis B and chronic hepatitis C in France: evidence for the role of HIV coinfection and alcohol consumption. J Hepatol 2008;48:200-207.
    • (2008) J Hepatol , vol.48 , pp. 200-207
    • Marcellin, P.1    Pequignot, F.2    Delarocque-Astagneau, E.3    Zarski, J.P.4    Ganne, N.5    Hillon, P.6
  • 36
    • 85056016967 scopus 로고    scopus 로고
    • Evolution des pratiques pour l'évaluation histologique des patients atteints d'hépatite chronique C traités entre 2003 et 2006: Analyse des 4546 patients des études Hepatys et Persee [in French] [Abstract]
    • Roudot-Thoraval F, Ouzan D, Denis J, Guyader D, Doffoel M, Delasalle P, et al. Evolution des pratiques pour l'évaluation histologique des patients atteints d'hépatite chronique C traités entre 2003 et 2006: analyse des 4546 patients des études Hepatys et Persee [in French] [Abstract]. Gastroenterol Clin Biol 2008;32:A92.
    • (2008) Gastroenterol Clin Biol , vol.32
    • Roudot-Thoraval, F.1    Ouzan, D.2    Denis, J.3    Guyader, D.4    Doffoel, M.5    Delasalle, P.6
  • 37
    • 33748883014 scopus 로고    scopus 로고
    • Review article: Management of patients with chronic hepatitis C virus infection and "normal" alanine aminotransferase activity
    • Zeuzem S, Alberti A, Rosenberg W, Marcellin P, Diago M, Negro F, et al. Review article: management of patients with chronic hepatitis C virus infection and "normal" alanine aminotransferase activity. Aliment Pharmacol Ther 2006;24:1133-1149.
    • (2006) Aliment Pharmacol Ther , vol.24 , pp. 1133-1149
    • Zeuzem, S.1    Alberti, A.2    Rosenberg, W.3    Marcellin, P.4    Diago, M.5    Negro, F.6
  • 38
    • 0037387851 scopus 로고    scopus 로고
    • Projecting future complications of chronic hepatitis C in the United States
    • Davis GL, Albright JE, Cook SF, Rosenberg DM. Projecting future complications of chronic hepatitis C in the United States. Liver Transpl 2003;9:331-338.
    • (2003) Liver Transpl , vol.9 , pp. 331-338
    • Davis, G.L.1    Albright, J.E.2    Cook, S.F.3    Rosenberg, D.M.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.